Prognostic Value of Tumor-Infiltrating Lymphocytes for Patients With Triple-Negative Breast Cancer-Reply

JAMA. 2024 Jul 23;332(4):337-338. doi: 10.1001/jama.2024.10483.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Female
  • Humans
  • Lymphocytes, Tumor-Infiltrating* / immunology
  • Prognosis
  • Randomized Controlled Trials as Topic
  • Triple Negative Breast Neoplasms* / immunology
  • Triple Negative Breast Neoplasms* / therapy